Predict your next investment

Venture Capital
kblhealthcare.com

See what CB Insights has to offer

Investments

26

Portfolio Exits

11

Funds

3

About KBL Healthcare Ventures

KBL Healthcare Ventures is a $100 million venture capital firm dedicated to investing in early stage and emerging growth healthcare companies. KBL alsoaims to manage KBL Healthcare Acquisition Corporation II, a publicly traded Special Purpose Acquisition fund with $50M under management. KBL's goal is to identify companies that are run by seasoned management teams and that have the potential to create long-term value. Within the medical device area, KBL seeks companies addressing large, unmet medical needs with demonstrated clinical benefit.

KBL Healthcare Ventures Headquarter Location

645 Madison Avenue

New York, New York, 10022-1010,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest KBL Healthcare Ventures News

CardioFocus Inks $5M In Debt Financing

Mar 21, 2011

CardioFocus Inks $5M In Debt Financing March 21, 2011 Venture capital-backed biotech company CardioFocus has secured $5 million in debt financing from Silicon Valley Bank. The company has raised venture funding from investors including Accuitive Medical Ventures, Aurora Funds, Kestrel Venture Management, Oxford Biosciences Partners, SV Life Sciences Advisors, HIG Ventures and KBL Healthcare Ventures. The debt financing will help it initiate its pivotal trial in the U.S. and to expand the commercialization of its products in Europe, the company said in a statement. CardioFocus is based in Massachusetts. PRESS RELEASE CardioFocus, a venture capital-backed medical device company developing technology to treat cardiac disorders, has secured $5M in debt financing from Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide. CardioFocus will use the new financing to initiate its pivotal trial in the United States and to expand the commercialization of its products in Europe. CardioFocus is dedicated to improving treatments for patients suffering from atrial fibrillation. With its Endoscopic Ablation System, CardioFocus is allowing physicians to truly visualize complex cardiac anatomy in living color for the first time and perform a transcatheter procedure to treat the millions of people worldwide affected by this cardiac disorder. “Silicon Valley Bank has been a trusted financial partner that understands our business imperatives and the progression of our technological and clinical accomplishments as we’ve grown,” said Stephen W. Sagon, President and CEO of CardioFocus. “Now that we are in critical phases of commercialization and global expansion, we appreciate SVB’s ability to provide the financing and global banking services we need to continue to grow.” “CardioFocus has been a client since it was just starting out,” said Michael Hanewich, head of life sciences for Silicon Valley Bank’s Eastern Division. “We exist to help life science companies as they develop amazing medical advances and bring them to market. We are a proud partner of CardioFocus and are excited to support their efforts as they expand their commercialization in Europe and seek FDA approval in the U.S.” Silicon Valley Bank’s experienced life science bankers offer a comprehensive suite of financing solutions, treasury management, corporate investment and international banking services to its clients worldwide. About Silicon Valley Bank Silicon Valley Bank provides commercial banking services to emerging growth and mature companies in the technology, life science, private equity and premium wine industries. Through its focus on specialized markets and extensive knowledge of the people and business issues driving them, Silicon Valley Bank provides a level of service and partnership that measurably impacts its clients’ success. Founded in 1983 and headquartered in Santa Clara, Calif., the company serves clients around the world through 26 U.S. offices and five international operations. Silicon Valley Bank is a member of global financial services firm SVB Financial Group (Nasdaq: SIVB), along with SVB Analytics, SVB Capital, SVB Global and SVB Private Client Services. More information on the company can be found at www.svb.com. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Financial Group is also a member of the Federal Reserve System. © 2015 Buyouts Insider / Argosy Group LLC

KBL Healthcare Ventures Investments

26 Investments

KBL Healthcare Ventures has made 26 investments. Their latest investment was in Neuronetics as part of their Series G on June 6, 2017.

CBI Logo

KBL Healthcare Ventures Investments Activity

investments chart

KBL Healthcare Ventures Portfolio Exits

11 Portfolio Exits

KBL Healthcare Ventures has 11 portfolio exits. Their latest portfolio exit was Neuronetics on June 28, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/28/2018

IPO

$99M

3

3/25/2016

Acquired

1

12/4/2014

Acquired

$99M

1

5/2/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/27/2012

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/28/2018

3/25/2016

12/4/2014

5/2/2014

3/27/2012

Exit

IPO

Acquired

Acquired

IPO

Acq - P2P

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

1

1

10

10

KBL Healthcare Ventures Fund History

3 Fund Histories

KBL Healthcare Ventures has 3 funds, including KBL Healthcare Ventures.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2000

KBL Healthcare Ventures

Early-Stage Venture Capital

Closed

$100M

1

12/31/2000

KBL Healthcare LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2000

KBL Partnership LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/31/2000

12/31/2000

12/31/2000

Fund

KBL Healthcare Ventures

KBL Healthcare LP

KBL Partnership LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Amount

$100M

$99M

$99M

Sources

1

10

10

KBL Healthcare Ventures Team

5 Team Members

KBL Healthcare Ventures has 5 team members, including current Managing Director, Michael D. Kaswan.

Name

Work History

Title

Status

Michael D. Kaswan

Managing Director

Current

Marlene R. Krauss

Managing Director

Current

Zachary C. Berk

Founder

Former

Jordan S. Davis

Managing Director

Former

Michael Kaswan

Managing Director

Former

Name

Michael D. Kaswan

Marlene R. Krauss

Zachary C. Berk

Jordan S. Davis

Michael Kaswan

Work History

Title

Managing Director

Managing Director

Founder

Managing Director

Managing Director

Status

Current

Current

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.